Mostrando 3 resultados de: 3
Anti-aging effect of metformin: A molecular and therapeutical perspective
ReviewAbstract: Aging is a time-dependent inevitable process, in which cellular homeostasis is affected, which has aPalabras claves:ageing, Anti-ageing drugs, Geronto-protective properties, Metformin, Type 2 Diabetes mellitusAutores:Cano-Ponce C., D’marco L., Galbán N., Gomez Y., González M.C., Herazo Y., Morillo V., Nava M., Rojas M., Rojas-Quintero J., Torres W., Valmore Bermúdez, Velasco M.Fuentes:scopusMicrobiota and diabetes mellitus: Role of lipid mediators
ReviewAbstract: Diabetes Mellitus (DM) is an inflammatory clinical entity with different mechanisms involved in itsPalabras claves:DIABÉTES, dysbiosis, inflammation, lipopolysaccharides, microbiota, Short-chain fatty acidsAutores:Añez-Ramos R., Cano-Ponce C., Dávila L.C.A., González M.C., Martínez M.S., Morillo V., Navarro C., Rajotia A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore BermúdezFuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus